Clincosm LogoSign in Get a demo

Influenza, Human

Showing 76 - 100 of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial in Worldwide (QIVc, Non-influenza Comparator Vaccine)

Completed
Has Results
  • Influenza, Human
  • QIVc
  • Non-influenza Comparator Vaccine
  • Sherwood, Queensland, Australia
  • +39 more
Oct 19, 2020

Influenza, Human Trial (Intervention letter, Control letter, Reminder)

Completed
  • Influenza, Human
  • Intervention letter
  • +2 more
  • (no location specified)
Sep 29, 2020

Influenza, Influenza -Like Illness, Influenza, Human Trial in Norfolk (Recombinant Influenza Vaccine, Standard Dose Quadrivalent

Unknown status
  • Influenza
  • +2 more
  • Recombinant Influenza Vaccine
  • Standard Dose Quadrivalent Influenza Vaccine
  • Norfolk, Virginia
    Insight Therapeutics, LLC
Sep 23, 2020

Cardiac Injury in Patients With Influenza

Recruiting
  • Influenza, Human
  • Myocardial Injury
    • Örebro, Sweden
      Örebro University
    Sep 15, 2020

    Influenza, Human Trial in United States (KT07 Capsule, Placebo)

    Completed
    • Influenza, Human
    • KT07 Capsule
    • Placebo
    • Birmingham, Alabama
    • +80 more
    Aug 27, 2020

    Influenza, Human Trial (IL-YANG Flu Vaccine QIV 0.5mL, IL-YANG Flu Vaccine TIV 0.5mL)

    Completed
    Has Results
    • Influenza, Human
    • IL-YANG Flu Vaccine QIV 0.5mL
    • IL-YANG Flu Vaccine TIV 0.5mL
    • (no location specified)
    Jul 28, 2020

    Influenza, Human Trial in United States (MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV),

    Completed
    Has Results
    • Influenza, Human
    • MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)
    • +2 more
    • Mobile, Alabama
    • +19 more
    Jul 20, 2020

    Influenza, Human, Pneumonia Trial (Sofia Fluorescent Immunoassay Analyzer Influenza A+B, Usual care)

    Completed
    • Influenza, Human
    • Pneumonia
    • Sofia Fluorescent Immunoassay Analyzer Influenza A+B
    • Usual care
    • (no location specified)
    Jun 12, 2020

    Influenza, Human Trial in Seoul (IL-YANG Quadrivalent Influenza Vaccine, IL-YANG Flu Vaccine Pre-filled Syringe)

    Completed
    • Influenza, Human
    • IL-YANG Quadrivalent Influenza Vaccine
    • IL-YANG Flu Vaccine Pre-filled Syringe
    • Seoul, Korea, Republic of
      The catholic university of Korea, Seoul ST. Marry's Hospital
    May 7, 2020

    Influenza, Human Trial in United States (3.75 ug Panblok H7, 7.5 ug Panblok H7, 15 ug Panblok H7)

    Completed
    Has Results
    • Influenza, Human
    • 3.75 ug Panblok H7
    • +4 more
    • Lenexa, Kansas
    • +3 more
    Apr 24, 2020

    Influenza, Human Trial in Belgium, Germany, Spain (Passive enhanced safety surveillance)

    Completed
    Has Results
    • Influenza, Human
    • Passive enhanced safety surveillance
    • Leuven, Belgium
    • +8 more
    Apr 23, 2020

    Influenza, Human Trial (H3N2)

    Completed
    • Influenza, Human
    • (no location specified)
    Apr 29, 2020

    Influenza, Human Trial in United States (NanoFlu, Fluzone Quadrivalent)

    Unknown status
    • Influenza, Human
    • NanoFlu
    • Fluzone Quadrivalent
    • Hollywood, Florida
    • +18 more
    Apr 16, 2020

    Strain Circulation and Disease Burden Study of Seasonal

    Completed
    Has Results
    • Influenza, Human
    • Data collection
    • Panama, Panama
      GSK Investigational Site
    Mar 22, 2020

    Influenza, Human Trial in Helsinki (Letter)

    Completed
    • Influenza, Human
    • Letter
    • Helsinki, Finland
      National Institute for Health and Welfare
    Feb 26, 2020

    Burden of Influenza at Emergency Department Level in European

    Unknown status
    • Influenza, Human
    • swab sampling
    • Rostock, Germany
      University of Rostock
    Jan 26, 2020

    Influenza, Human, Immune Response Trial in Pittsburgh (Flucelvax inactivated influenza vaccine, Fluzone inactivated influenza

    Completed
    Has Results
    • Influenza, Human
    • Immune Response
    • Flucelvax inactivated influenza vaccine
    • Fluzone inactivated influenza vaccine
    • Pittsburgh, Pennsylvania
    • +1 more
    Jan 7, 2020

    Surveillance of Seasonal Influenza Vaccines: Pilot Study in

    Completed
    Has Results
    • Influenza, Human
    • Enhanced vaccine safety surveillance
    • Surrey, United Kingdom
      GSK Investigational Site
    Jan 9, 2020

    Influenza, Human Trial in Mexico (Study group - quadrivalent recombinant hemagglutinin influenza vaccine, Control group -

    Completed
    • Influenza, Human
    • Study group - quadrivalent recombinant hemagglutinin influenza vaccine
    • Control group - quadrivalent inactivated influenza vaccine
    • Saltillo, Coahuila, Mexico
    • +10 more
    Nov 12, 2019

    Influenza, Human Trial in Hong Kong (Celecoxib, Oseltamivir, Placebo)

    Completed
    • Influenza, Human
    • Hong Kong, Hong Kong
      Ivan Hung
    Oct 18, 2019

    Influenza, Human Trial in Saint Louis (MER4101, Inactivated Influenza Vaccine)

    Unknown status
    • Influenza, Human
    • MER4101
    • Inactivated Influenza Vaccine
    • Saint Louis, Missouri
      Saint Louis University School of Medicine
    Sep 4, 2019

    Influenza, Human Trial (Intervention letter)

    Completed
    • Influenza, Human
    • Intervention letter
    • (no location specified)
    Aug 27, 2019

    Inactivated Influenza Vaccine in Healthy Adults

    Completed
    • Influenza
    • +6 more
    • Influenza Vaccine Recipients
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Aug 2, 2019

    Influenza, Human Trial in Ho Chi Minh City (IVACFLU-S, Placebo)

    Completed
    Has Results
    • Influenza, Human
    • IVACFLU-S
    • Placebo
    • Ho Chi Minh City, Vietnam
      Pasteur Institute, Ho Chi Minh City
    May 12, 2019

    Influenza, Influenza, Human Trial in Wilrijk (Influenza Vaccine GSK1247446A, Fluarix™)

    Completed
    Has Results
    • Influenza
    • Influenza, Human
    • Influenza Vaccine GSK1247446A
    • Fluarix™
    • Wilrijk, Belgium
      GSK Investigational Site
    Jun 13, 2019